Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

June 9, 2022
BioUtah News
University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization

MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The BACF was […]

June 9, 2022
BioUtah News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis

CAMBRIDGE, Mass., June 8, 2022 /PRNewswire/ — Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food Drug and Administration (FDA) granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis. “This designation is an important milestone in […]

June 9, 2022
BioUtah News
ELEVAR THERAPEUTICS SHARES RESULTS OF PHASE 2 RIVOCERANIB TRIAL IN PATIENTS WITH PROGRESSIVE RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA

CHICAGO, June 06, 2022 — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today detailed the results of its Phase 2 clinical trial (Study RM-202) of rivoceranib, an orally administered tyrosine kinase inhibitor (TKI), in patients with progressive recurrent […]

June 8, 2022
BioUtah News
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox

CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit

June 7, 2022
BioUtah News
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET

Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in Smart, Connected Care and Enable New Care Settings Expected to be Immediately Accretive to Revenue Growth, Adjusted Operating Margins and Adjusted EPS; Enhances Ability to Achieve Long-Range Sales […]

June 6, 2022
BioUtah News
KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease

June 6, 2022
BioUtah News
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor

June 6, 2022
BioUtah News
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.

May 31, 2022
BioUtah News
Biomerics announces expansion in Ireland with a new facility in Galway

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway

May 31, 2022
BioUtah News
Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

May 26, 2022
Policy News
Invest Lithuania

BioUtah has established a partnership with Invest Lithuania, an arm of the Lithuanian government focused on developing life sciences in their country. The life sciences sector in Lithuania is regarded as one of the most highly developed in Central and Eastern Europe (CEE). The sector is driven by innovation and aims to become Europe’s next […]

May 26, 2022
BioUtah News
Biomerics Announces Image Guided Intervention Division

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

May 25, 2022
BioUtah News
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

May 18, 2022
BioUtah News
PolarityTE to Effectuate 1-for-25 Reverse Stock Split

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock.

May 16, 2022
BioUtah News
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

May 16, 2022
BioUtah News
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

May 12, 2022
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
BioHive Takes the Stage at One Utah Summit

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]

May 12, 2022
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]

May 12, 2022
BioUtah News
Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]

May 11, 2022
BioUtah News
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

May 11, 2022
BioUtah News
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

May 11, 2022
BioUtah News
New Executive Appointments Position ARUP Laboratories for Future Growth

New Executive Appointments Position ARUP Laboratories for Future Growth

May 11, 2022
BioUtah News
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.

May 5, 2022
Policy News
E&C Leaders Unveil FDA User Fees Legislative Package

Bipartisan Agreement Will Support Innovation, Lower Costs, and Improve People’s Lives Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Cathy McMorris Rodgers (R-WA), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), and Health Subcommittee Ranking Member Brett Guthrie (R-KY) today unveiled a comprehensive legislative package to reauthorize the Food and Drug […]

May 5, 2022
BioUtah News
Biomerics Announces Image Guided Intervention (IGI) Division

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

May 5, 2022
BioUtah News
Genovac Acquires Platform for Antibody Screening and Characterization Services

Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]

May 5, 2022
BioUtah News
CoNextions TR Tendon Repair System receives FDA clearance

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

May 5, 2022
BioUtah News
Blackrock Neurotech and Phantom Neuro Partner to Enable Prosthetics and Exoskeletons that Mimic Human Movement in Real-Time

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

May 5, 2022
BioUtah News
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]

May 5, 2022
BioUtah News
BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULT

FRANKLIN LAKES, N.J., May 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal year 2022, which ended March 31, 2022. Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of […]

May 5, 2022
BioUtah News
BD Announces Inaugural Members of Scientific Advisory Board

Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J., May 2, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the inaugural members of the BD Scientific Advisory Board (SAB), which is comprised […]

May 5, 2022
BioUtah News
Cibus Biotechnologies Celebrates a New Home, New Name

The innovation blooming in Utah’s BioHive was on full display Wednesday at a ribbon-cutting ceremony announcing a new home and new name for Cibus Biotechnologies. Under the new name, Seek Labs, the company has moved to a new location at Salt Lake City’s Northgate. The new location offers expanded laboratory facilities and room to grow. […]